200 related articles for article (PubMed ID: 29384065)
1. IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway.
Yu J; Da J; Dong R; Sun Y; Nie Y; Yu F; Zuo L; Zha Y
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):241-250. PubMed ID: 29384065
[TBL] [Abstract][Full Text] [Related]
2. High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model.
Yu J; Dong R; Da J; Li J; Yu F; Zha Y
Kidney Blood Press Res; 2019; 44(3):331-343. PubMed ID: 31203283
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
4. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
5. HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4.
Yu J; Da J; Yu F; Yuan J; Zha Y
J Endocrinol Invest; 2024 Apr; 47(4):1015-1027. PubMed ID: 38409569
[TBL] [Abstract][Full Text] [Related]
6. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.
Kong YL; Shen Y; Ni J; Shao DC; Miao NJ; Xu JL; Zhou L; Xue H; Zhang W; Wang XX; Lu LM
Acta Pharmacol Sin; 2016 Feb; 37(2):217-27. PubMed ID: 26775660
[TBL] [Abstract][Full Text] [Related]
7. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
Yu R; Bo H; Villani V; Spencer PJ; Fu P
Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2.
Li J; Dong R; Yu J; Yi S; Da J; Yu F; Zha Y
Drug Des Devel Ther; 2018; 12():2887-2896. PubMed ID: 30254418
[TBL] [Abstract][Full Text] [Related]
9. Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4.
Lian H; Cheng Y; Wu X
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696221
[TBL] [Abstract][Full Text] [Related]
10. IGF-1/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail1 expression in a mouse model.
Dong R; Yu J; Yu F; Yang S; Qian Q; Zha Y
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E686-E698. PubMed ID: 31361542
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling.
Yang S; Deng H; Zhang Q; Xie J; Zeng H; Jin X; Ling Z; Shan Q; Liu M; Ma Y; Tang J; Wei Q
PLoS One; 2016; 11(3):e0151857. PubMed ID: 26986757
[TBL] [Abstract][Full Text] [Related]
13. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Tangshenling Mixture and benazepril on rats with diabetic nephropathy and its mechanism].
He XL; Li JP; Chen YP; Zhang ZG; Lin WQ; Chen JH
Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):43-7. PubMed ID: 16409969
[TBL] [Abstract][Full Text] [Related]
15. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
16. Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF-κB pathway in mice.
Cai S; Chen J; Li Y
Immunobiology; 2020 May; 225(3):151941. PubMed ID: 32359778
[TBL] [Abstract][Full Text] [Related]
17. Ramipril can alleviate the accumulation of renal mesangial matrix in rats with diabetic nephropathy by inhibiting insulin-like growth factor-1.
Ren W; Zhao C; Wang Y; Fang Y; Huang Z; Chen W; Wang L; Hu W; Wang K; Ni L
Acta Cir Bras; 2019 Feb; 34(1):e20190010000007. PubMed ID: 30785508
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
